The University Medical Center Hamburg-Eppendorf is the teaching hospital of the University of Hamburg and one of the largest hospitals in Hamburg, Germany. The UKE has 1,460 beds and 121 day-care places and is listed to provide the capacity to dispatch emergency medical services.

There are 1,460 beds in University Hospital Hamburg Eppendorf.

During the past decade, University Hospital Hamburg Eppendorf conducted 67 clinical trials. In the 10-year time frame, 67 clinical trials started and 9 clinical trials were completed, i.e. on average, 13.4% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 5 clinical trials were completed. i.e. 18.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital Hamburg Eppendorf" #1 sponsor was "Universitätsklinikum Hamburg-Eppendorf" with 42 trials, followed by "European Society for Blood and Marrow Transplantation" with 7 trials sponsored, "Celgene" with 3 trials sponsored, "University of Ulm" with 3 trials sponsored and "medac GmbH" with 3 trials sponsored. Other sponsors include 57 different institutions and companies that sponsored additional 61 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Hamburg Eppendorf" #1 collaborator was "Universitätsklinikum Hamburg-Eppendorf" with 5 trials as a collaborator, "German Federal Ministry of Education and Research" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Charite University, Berlin, Germany" with 2 trials as a collaborator and "Goethe University" with 2 trials as a collaborator. Other collaborators include 104 different institutions and companies that were collaborators in the rest 112 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital Hamburg Eppendorf" are "Acute Myeloid Leukemia" (4 trials), "Multiple Myeloma" (4 trials), "Crohn Disease" (3 trials), "Schizophrenia" (3 trials) and "Acute Ischemic Stroke" (2 trials). Many other conditions were trialed in "University Hospital Hamburg Eppendorf" in a lesser frequency.

Most popular intervention types in "University Hospital Hamburg Eppendorf" are "Drug" (53 trials), "Other" (23 trials), "Procedure" (18 trials), "Device" (11 trials) and "Behavioral" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Dexamethasone" (4 trials), "JNJ-73763989" (4 trials), "Cytarabine" (3 trials) and "JNJ-56136379" (3 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Hamburg Eppendorf" are 113 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "University Hospital Hamburg Eppendorf". undefined are not yet recruiting, 29 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 48 completed trials in University Hospital Hamburg Eppendorf, 1 suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Hamburg Eppendorf, 12 "Phase 1" clinical trials were conducted, 29 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 33 trials that are defined as “Not Applicable".